Relief Therapeutics Holding GAAP EPS of -CHF 1.37, revenue of CHF 9.83B
Source: SeekingAlpha
2025-04-10 03:04:56 ET
More on Relief Therapeutics Holding SA
Read the full article on Seeking Alpha
For further details see:
Relief Therapeutics Holding GAAP EPS of -CHF 1.37, revenue of CHF 9.83B
Mondobiotech Holding AG Basel
NASDAQ: RLFTF
RLFTF Trading
1.07% G/L:
$0.5839 Last:
1,416 Volume:
$0.59315 Open:
RLFTF Latest News
December 23, 2025 01:20:00 am
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
December 15, 2025 01:20:00 am
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
November 14, 2025 12:40:00 pm
Relief Therapeutics Shareholders Approve Business Combination with NeuroX
October 29, 2025 02:20:00 am
Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
RLFTF Stock Data
$18,486,601
12,379,921
N/A
1
N/A
Biotechnology & Life Sciences
Healthcare
CH
Geneva
